Administered via once-weekly injections, Wegovy works alongside diet and exercise to help individuals achieve and maintain significant weight loss
However, these medications are not subject to FDA approval and are not evaluated for safety or effectiveness
[1] [2] The primary indications remain type 2 diabetes mellitus and obesity management in carefully selected patients
Together, the compounding pharmacies may account for up to 30% of the semaglutide sold in the U.S., Mikhael said, although he cautions that is a wild ballpark figure since no one, including the FDA, is tracking sales in the industry
What safety risks exist with compounded semaglutide
NSAIDs can delay disease onset, ameliorate symptomatic severity, and slow cognitive decline [15]